Rep. Gilbert Ray Cisneros, Jr. Buys Globus Medical, Inc. (NYSE:GMED) Shares
by Renee Jackson · The Cerbat GemRepresentative Gilbert Ray Cisneros, Jr. (Democratic-California) recently bought shares of Globus Medical, Inc. (NYSE:GMED). In a filing disclosed on April 07th, the Representative disclosed that they had bought between $1,001 and $15,000 in Globus Medical stock on March 3rd.
Representative Gilbert Ray Cisneros, Jr. also recently made the following trade(s):
- Sold $1,001 – $15,000 in shares of MACOM Technology Solutions (NASDAQ:MTSI) on 3/27/2026.
- Purchased $1,001 – $15,000 in shares of StandardAero (NYSE:SARO) on 3/27/2026.
- Purchased $1,001 – $15,000 in shares of FirstService (NASDAQ:FSV) on 3/27/2026.
- Sold $1,001 – $15,000 in shares of Charles Schwab (NYSE:SCHW) on 3/27/2026.
- Sold $1,001 – $15,000 in shares of Advanced Energy Industries (NASDAQ:AEIS) on 3/27/2026.
- Sold $1,001 – $15,000 in shares of Flex (NASDAQ:FLEX) on 3/27/2026.
- Purchased $1,001 – $15,000 in shares of LPL Financial (NASDAQ:LPLA) on 3/27/2026.
- Purchased $1,001 – $15,000 in shares of DoorDash (NASDAQ:DASH) on 3/27/2026.
- Sold $1,001 – $15,000 in shares of Viavi Solutions (NASDAQ:VIAV) on 3/27/2026.
- Purchased $15,001 – $50,000 in shares of Fabrinet (NYSE:FN) on 3/27/2026.
Globus Medical Stock Up 0.3%
Shares of NYSE GMED traded up $0.30 during mid-day trading on Thursday, reaching $92.26. 257,250 shares of the company were exchanged, compared to its average volume of 1,257,030. Globus Medical, Inc. has a 1 year low of $51.79 and a 1 year high of $101.40. The firm has a 50-day moving average of $88.66 and a 200 day moving average of $81.89. The stock has a market cap of $12.48 billion, a price-to-earnings ratio of 23.42, a P/E/G ratio of 2.05 and a beta of 1.09.
Globus Medical (NYSE:GMED – Get Free Report) last posted its earnings results on Tuesday, February 24th. The medical device company reported $1.28 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.06 by $0.22. The company had revenue of $826.42 million for the quarter, compared to analyst estimates of $803.29 million. Globus Medical had a return on equity of 12.57% and a net margin of 18.30%.The firm’s quarterly revenue was up 25.7% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.84 earnings per share. On average, equities analysts forecast that Globus Medical, Inc. will post 3.44 earnings per share for the current year.
Insiders Place Their Bets
In other Globus Medical news, EVP Kelly Huller sold 20,000 shares of the firm’s stock in a transaction that occurred on Wednesday, February 25th. The shares were sold at an average price of $94.50, for a total transaction of $1,890,000.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Company insiders own 18.51% of the company’s stock.
Institutional Inflows and Outflows
A number of hedge funds have recently bought and sold shares of the stock. Invesco Ltd. grew its holdings in shares of Globus Medical by 1,235.2% during the fourth quarter. Invesco Ltd. now owns 3,886,405 shares of the medical device company’s stock valued at $339,322,000 after buying an additional 3,595,339 shares during the last quarter. Bank of Montreal Can grew its stake in Globus Medical by 15,317.1% during the 4th quarter. Bank of Montreal Can now owns 3,373,260 shares of the medical device company’s stock valued at $294,519,000 after purchasing an additional 3,351,380 shares during the last quarter. Alliancebernstein L.P. increased its holdings in shares of Globus Medical by 1,303.9% in the third quarter. Alliancebernstein L.P. now owns 2,055,183 shares of the medical device company’s stock valued at $117,700,000 after purchasing an additional 1,908,795 shares during the period. Boston Trust Walden Corp purchased a new position in shares of Globus Medical in the third quarter worth about $67,891,000. Finally, Fuller & Thaler Asset Management Inc. purchased a new stake in Globus Medical in the fourth quarter valued at approximately $90,411,000. Institutional investors and hedge funds own 95.16% of the company’s stock.
Wall Street Analysts Forecast Growth
Several research analysts recently commented on GMED shares. Zacks Research upgraded shares of Globus Medical from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, March 3rd. Wall Street Zen raised shares of Globus Medical from a “buy” rating to a “strong-buy” rating in a report on Saturday, January 3rd. Needham & Company LLC upped their price target on Globus Medical from $112.00 to $114.00 and gave the stock a “buy” rating in a research report on Wednesday, February 25th. Citigroup reiterated a “market perform” rating on shares of Globus Medical in a report on Thursday, January 8th. Finally, BTIG Research reissued a “neutral” rating on shares of Globus Medical in a research report on Tuesday, December 30th. Three analysts have rated the stock with a Strong Buy rating, eight have assigned a Buy rating and five have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $104.36.
Read Our Latest Analysis on Globus Medical
About Representative Cisneros
Gil Cisneros (Democratic Party) is a member of the U.S. House, representing California’s 31st Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.
Cisneros (Democratic Party) is running for re-election to the U.S. House to represent California’s 31st Congressional District. He declared candidacy for the 2026 election.
Gil Cisneros served in the U.S. Navy as a supply officer from 1994 to 2004. Cisneros earned a bachelor’s degree in political science from George Washington University in 1994, a master’s in business administration from Regis University in 2002, and a master’s degree in urban education policy from Brown University in 2015. His career experience includes working as a logistics manager for Frito-Lay. In 2010, Cisneros won the lottery and became involved in activism and philanthropy, founding a scholarship program for local high school students. In 2021, President Joe Biden (D) appointed Cisneros as under secretary of defense for personnel and readiness.
Globus Medical Company Profile
Globus Medical, Inc (NYSE:GMED) is a leading medical device company specializing in musculoskeletal solutions for spine and orthopaedic applications. Founded in 2003 by David C. Paul and headquartered in Audubon, Pennsylvania, the company develops, manufactures and markets implantable devices and surgical instruments designed to treat spinal disorders and promote bone healing. Its product portfolio encompasses solutions for minimally invasive and open surgical procedures, including interbody fusion devices, pedicle screw systems, and biologics used to enhance fusion outcomes.
In addition to its core spine business, Globus Medical has expanded into robotics and navigation systems to support precision and efficiency in the operating room.